IL6 and long COVID-19: Taken together, our study demonstrated that neither serum levels of Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), and Tumor necrosis factor alpha (TNFα), nor cortisol are suitable biomarkers to identify patients with PASC.